Osteogenesis Imperfecta: A Clinical Clerkship Guide

High-Yield Summary

• Definition: A heterogeneous group of genetic disorders characterized by bone fragility and low bone mass, primarily due to defects in type I collagen synthesis [1], [2].
• Classic Triad: Bone fragility (recurrent fractures), blue sclerae, and dentinogenesis imperfecta [1], [3].
• Inheritance: Most commonly autosomal dominant, but can be recessive or sporadic [1], [2].
• Pathophysiology: Mutations in COL1A1 or COL1A2 genes are most common, affecting the production or structure of type I collagen [2], [4].
• Diagnosis: Clinical features, imaging (osteopenia, Wormian bones), and definitive genetic testing [1], [2].
• Management: Multidisciplinary approach including bisphosphonates, orthopedic surgery (rodding), physical therapy, and pain control [1], [5].
• Do Not Miss: Differentiating from non-accidental trauma (child abuse) is crucial [1], [6].

Definition / Overview

Osteogenesis Imperfecta (OI), commonly known as 'brittle bone disease', is a diverse group of inherited connective tissue disorders primarily affecting bone quality and quantity [2], [7]. It is characterized by bone fragility, leading to recurrent fractures with minimal or no trauma [7].

OI results from defects in the synthesis, structure, or processing of type I collagen, which is the most abundant protein in bone and crucial for its strength [2], [4]. While often thought of as a single entity, OI encompasses a broad spectrum of clinical severity, ranging from perinatal lethal forms to very mild presentations with only a few fractures in a lifetime [1], [2].

The classification of OI has evolved. Historically, it was divided into four main types (Sillence classification: Types I-IV) based on clinical and genetic features [1]. However, molecular discoveries have expanded this to over 20 recognized types, with Type I being the most common and mildest form, and Type II being the most severe (often lethal in utero or perinatally) [1], [8].

Epidemiology

Osteogenesis Imperfecta is a rare disease, with an estimated prevalence ranging from 1 in 10,000 to 1 in 20,000 live births globally [9]. It affects males and females equally and occurs in all ethnic groups [9].

The majority of cases (approximately 90%) are inherited in an autosomal dominant pattern, typically involving a new spontaneous mutation or inheritance from an affected parent [2], [8]. Autosomal recessive forms and X-linked forms are less common but recognized [1], [4]. Approximately 25-30% of cases are due to de novo mutations, meaning there is no family history, which can make diagnosis challenging [6], [9].

Pathophysiology

The primary pathogenic mechanism in the vast majority of OI cases involves quantitative or qualitative defects in type I collagen [1], [4]. Type I collagen is a heterotrimer composed of two α1(I) chains (encoded by the COL1A1 gene) and one α2(I) chain (encoded by the COL1A2 gene) [2]. These chains form a triple helix, providing structural integrity to bone, skin, tendons, ligaments, and sclerae [4].

• Type I Collagen Quantity Defects: Most commonly associated with OI Type I, resulting from haploinsufficiency (e.g., nonsense mutations in COL1A1) leading to reduced production of normal type I collagen. This results in less, but structurally normal, collagen [1], [2].
• Type I Collagen Quality Defects: Typically more severe, associated with OI Types II, III, and IV. These involve missense mutations (often glycine substitutions) that lead to abnormal collagen triple helix formation, misfolding, and increased degradation. This 'dominant negative' effect results in the production of structurally abnormal collagen [1], [2].

Beyond COL1A1 and COL1A2, mutations in numerous other genes involved in collagen processing, post-translational modification, or bone mineralization (e.g., CRTAP, P3H1, SERPINH1, IFITM5) have been identified, leading to the broader spectrum of OI types [1], [4]. These non-collagenous OI forms often involve proteins in the collagen prolyl-3-hydroxylation complex [1].

Clinical Presentation

The clinical presentation of OI is highly variable, reflecting the underlying genetic heterogeneity and severity [1], [2]. Key features include:

• Bone Fragility: Recurrent fractures are the hallmark, often with minimal or no trauma. Fracture presentation varies greatly with OI type, from multiple fractures in utero (Type II) to only a few fractures in adulthood (Type I) [1], [8].
• Blue Sclerae: The sclerae appear blue, grey, or purple due to the thinning of the scleral collagen, allowing the underlying choroidal veins to show through [1], [9]. This is typical of Type I; in Type IV the sclerae are usually white or near-white [1], [6].
• Dentinogenesis Imperfecta (DI): Affects both primary and permanent teeth, causing opalescent, discoloured (bluish-grey or yellowish-brown), fragile teeth that are prone to wear and fracture [1], [2]. This is less common in Type I.
• Hearing Loss: Occurs in approximately 50% of individuals, typically starting in early adulthood. It can be conductive (due to otosclerosis or ossicular chain abnormalities) or sensorineural [1], [2].
• Short Stature: Common, especially in more severe types (II, III, IV), due to vertebral compression fractures and long bone deformities [1], [8].
• Skeletal Deformities: Progressive kyphoscoliosis, bowing of long bones, and barrel-shaped chest are common, particularly in Types III and IV [1], [8].
• Joint Hypermobility: Ligamentous laxity can lead to joint instability and dislocations [1].
• Other Features: Easy bruising, excessive sweating, heat intolerance, thin skin, and mild cardiovascular abnormalities (e.g., aortic root dilation in some types, although less common than in Marfan syndrome) [1], [2].

Clinical Pearl: The severity of OI is often inversely related to the collagen quantity produced; severe forms (Type II, III) usually involve qualitatively abnormal collagen, while milder forms (Type I) involve reduced amounts of normal collagen [1].

Red Flags

The presence of certain clinical features should raise suspicion for osteogenesis imperfecta and prompt further investigation, especially to differentiate from non-accidental trauma [1], [6].

• Multiple Fractures: Especially recurrent fractures with trivial trauma, or fractures inconsistent with the reported mechanism, particularly in infants or young children [6], [10].
• Fractures in Atypical Locations: Posteromedial rib, classic metaphyseal, scapular, sternal and spinous process fractures are highly specific for abuse [18], although rib fractures also occur in OI [6]. Without significant trauma, they call for a full evaluation that weighs both diagnoses.
• Blue Sclerae: A prominent and relatively specific finding, though less common in some severe OI types [1], [3].
• Family History: A history of brittle bones or blue sclerae in a parent or sibling strongly suggests OI [2], [6].
• Early or Severe Osteopenia: On imaging, particularly without other clear causes [1].
• Wormian Bones: Presence of numerous, small, irregular bones within the cranial sutures on skull radiographs [1].
• Dentinogenesis Imperfecta: Discolored, translucent, or abnormally shaped teeth [1], [2].

⚠️ Do Not Miss: Always consider osteogenesis imperfecta in the differential diagnosis of recurrent fractures in children. Misdiagnosis as child abuse can have devastating consequences for families, while missing OI delays appropriate management [6], [10]. Conversely, ensure thorough investigation to rule out abuse when OI is suspected, as the two can co-exist: non-accidental injury has been reported in a child with severe OI [1], [19].

Diagnosis

Diagnosis of osteogenesis imperfecta is typically based on a combination of clinical features, radiological findings, and molecular genetic testing [1], [2].

Clinical Assessment

• Detailed history focusing on fracture history (number, age, mechanism), family history, and other associated symptoms (blue sclerae, hearing loss, dental issues) [1].
• Physical examination to assess for blue sclerae, dentinogenesis imperfecta, joint hyperlaxity, short stature, and skeletal deformities (e.g., kyphoscoliosis, bowing of long bones) [1].

Radiological Findings

• Skeletal Survey: Essential for evaluating current and past fractures, assessing bone density, and identifying characteristic features [1].
• Findings may include:
  • Generalized osteopenia (reduced bone density) [1].
  • Multiple fractures at various stages of healing [6].
  • Bowing and deformities of long bones [1].
  • Vertebral compression fractures, leading to platyspondyly [1].
  • Wormian bones (small, irregular bones within cranial sutures), particularly prominent in OI Types I and III [1].
  • Scoliosis or kyphoscoliosis [1].
• DEXA Scan: Measures bone mineral density (BMD), often showing low BMD for age and sex [1], [5].

Genetic Testing

• Molecular Genetic Testing: Considered the gold standard for definitive diagnosis and for identifying the specific OI type, which can guide prognosis and management [2].
• Approaches:
  • Targeted gene sequencing (e.g., COL1A1, COL1A2) for common types [2].
  • Next-generation sequencing panels covering known OI-associated genes [2].
  • Whole exome sequencing in atypical or challenging cases [2].
• Prenatal Diagnosis: Available through amniocentesis or chorionic villus sampling if a causative mutation is identified in the family [2].

Bone biopsy and collagen analysis are largely research tools and rarely required for routine clinical diagnosis [2].

Management

Management of osteogenesis imperfecta is multidisciplinary and focuses on preventing fractures, minimizing pain and deformities, maximizing mobility, and improving quality of life [1], [5]. There is no cure for OI.

Medical Management

• Bisphosphonates: The cornerstone of medical therapy, particularly for moderate to severe forms. They work by inhibiting osteoclast activity, thereby reducing bone resorption and increasing bone mineral density.
  • Intravenous Bisphosphonates: Pamidronate and zoledronic acid are commonly used in children and adults with OI in Canada [4], [11]. They have been shown to reduce fracture rates, increase bone density, and improve pain [1], [11].
  • Oral Bisphosphonates: Less commonly used in severe OI due to variable absorption, but may be considered for milder cases [11].
• Vitamin D and Calcium Supplementation: Essential to optimize bone health, especially in those on bisphosphonate therapy [5].
• Pain Management: Chronic pain is common. Requires a comprehensive approach including analgesics, physical therapy, and psychological support [4], [5].

Surgical Management

• Intramedullary Rodding: Insertion of telescoping or fixed intramedullary rods into long bones (e.g., femur, tibia) to prevent fractures and correct bowing deformities [1], [12]. This is particularly important for individuals with severe and recurrent long bone fractures.
• Correction of Deformities: Orthopedic surgery may also address scoliosis, kyphosis, or other significant skeletal deformities [1].

Rehabilitative and Supportive Care

• Physical Therapy: Crucial for strengthening muscles, improving balance, increasing mobility, and reducing the risk of falls and fractures [5], [12]. Hydrotherapy can be particularly beneficial.
• Occupational Therapy: Adapting environments and providing assistive devices to promote independence and safety [5].
• Mobility Aids: Wheelchairs, walkers, and braces may be necessary for individuals with more severe mobility limitations [1], [5].
• Dental Care: Regular dental check-ups and specialized care for individuals with dentinogenesis imperfecta to prevent tooth fractures and cavities [5].
• Audiology: Regular hearing assessments, and hearing aids or cochlear implants if necessary for progressive hearing loss [5].
• Psychosocial Support: Addressing the psychological and social impact of a chronic illness, including pain, limitations, and body image issues [4], [5].

Complications

Osteogenesis Imperfecta can lead to a variety of short-term and long-term complications, impacting multiple organ systems [4].

• Skeletal Complications:
  • Chronic Pain: Due to repeated fractures, deformities, and joint issues [4].
  • Permanent Skeletal Deformities: Severe bowing of long bones, kyphoscoliosis, and short stature can significantly impact mobility and function [1].
  • Non-union or Malunion of Fractures: Although bones usually heal well in OI, severe cases or poor management can lead to these complications [1].
• Respiratory Complications: Thoracic cage deformities (e.g., barrel chest, severe kyphoscoliosis) can restrict lung expansion, leading to restrictive lung disease, recurrent respiratory infections, and respiratory insufficiency [4].
• Neurological Complications: Basilar invagination (protrusion of the brainstem into the foramen magnum) can occur due to skull base abnormalities, potentially causing neurological symptoms like hydrocephalus, cranial nerve palsies, and brainstem compression [1].
• Audiological Complications: Progressive conductive or sensorineural hearing loss, often beginning in adulthood [1], [2].
• Dental Complications: Dentinogenesis imperfecta leads to fragile teeth prone to decay and fracture, affecting mastication and aesthetics [1].
• Cardiovascular Complications: While less common than in some other connective tissue disorders, some individuals with OI can develop aortic root dilation, mitral valve prolapse, or aortic regurgitation due to collagen defects affecting blood vessel walls [1].
• Psychosocial Complications: Chronic pain, physical limitations, frequent hospitalizations, and visible deformities can lead to anxiety, depression, and social isolation [4], [5].

Differential Diagnosis

When evaluating a child with suspected osteogenesis imperfecta, it is crucial to consider other conditions that can cause bone fragility or mimic its presentation [1], [10].

• Non-Accidental Trauma (Child Abuse): This is the most critical differential diagnosis. Both OI and child abuse can present with multiple fractures, some in various stages of healing. Careful evaluation of fracture patterns, clinical features (e.g., blue sclerae, dentinogenesis imperfecta), and a comprehensive history are essential to differentiate [6], [10].
• Rickets: Caused by vitamin D deficiency or impaired vitamin D metabolism, leading to soft bones and deformities. Unlike OI, rickets typically presents with characteristic metaphyseal flaring on X-rays and biochemical abnormalities (low vitamin D, abnormal calcium/phosphate) [13].
• Idiopathic Juvenile Osteoporosis (IJO): A rare condition characterized by low bone density and fractures in otherwise healthy children, usually resolving spontaneously. Unlike OI, there are no other systemic features like blue sclerae or dentinogenesis imperfecta [14].
• Other Genetic Bone Disorders:
  • Hypophosphatasia: Impaired bone mineralization due to alkaline phosphatase deficiency. Can cause bone fragility and skeletal deformities but also presents with early tooth loss and often elevated serum calcium/phosphate [15].
  • Ehlers-Danlos Syndrome (EDS): Primarily affects skin and joint laxity. While some types can involve osteopenia, severe bone fragility and blue sclerae are not typical features [16].
  • Loeys-Dietz Syndrome: Connective tissue disorder with skeletal features and vascular fragility (aortic aneurysms/dissections). Shares some features like joint hyperlaxity but distinct vascular risks [17].
• Nutritional Deficiencies: Severe calcium or protein deficiency can rarely lead to bone fragility.
• Long-term Medication Use: Certain medications, like long-term corticosteroids, can induce osteoporosis [14].

Clinical Pearl: If you see multiple fractures in an infant or young child, always think: 1) Non-accidental trauma, 2) Osteogenesis Imperfecta, 3) Rickets. A thorough diagnostic workup is necessary to distinguish between these potentially devastating conditions [6], [10], [13].

Exam Pearls

• Classic Triad: Remember the core features of OI for exam questions: bone fragility (recurrent fractures), blue sclerae, and dentinogenesis imperfecta [1], [3]. Type I collagen defects are the underlying cause.
• Differential for Recurrent Fractures: If asked about recurrent fractures in a child, the top three differentials are usually Osteogenesis Imperfecta, Non-Accidental Trauma (Child Abuse), and Rickets [6], [10], [13]. Be ready to differentiate them.
• Sillence Classification: While many new types exist, understanding the four classic Sillence types (I-IV) helps categorize severity and common presentations:
  • Type I: Mildest, blue sclerae, normal stature, least deformity [1], [8].
  • Type II: Perinatal lethal, severe bone fragility, crumpled long bones, broad ribs [1], [8].
  • Type III: Severe progressive deformity, multiple fractures, often short stature, white/grey sclerae [1], [8].
  • Type IV: Moderate severity, often normal sclerae, variable stature/deformity [1], [8].
• Wormian Bones: A characteristic radiological finding on skull X-rays, particularly in Type I and III [1].
• Management Focus: Bisphosphonates and orthopedic rodding are key medical and surgical interventions, respectively [1], [11]. Remember the multidisciplinary approach.

Common Traps / Pitfalls

• Missing the Diagnosis: Because of its rarity and variable presentation, milder forms of OI can be overlooked, or symptoms attributed to normal childhood accidents [6]. A high index of suspicion is needed.
• Misdiagnosing as Child Abuse: This is a critical and potentially devastating pitfall. Fractures in OI can mimic child abuse, especially in infants. A thorough history, physical exam, skeletal survey, and genetic testing are vital to avoid wrongful accusations [6], [10]. Remember, presence of blue sclerae and DI are strong indicators of OI and are not seen in child abuse [6].
• Attributing All Fractures to OI: While rare, children with OI can also be victims of abuse. The diagnosis of OI does not automatically exclude non-accidental trauma, especially if fracture patterns are highly suspicious.
• Ignoring Non-Skeletal Manifestations: Focusing solely on bones and missing other significant features like blue sclerae, dentinogenesis imperfecta, hearing loss, or potential cardiovascular issues [1], [2].
• Inadequate Multidisciplinary Care: OI management requires input from orthopedics, physiatry, genetics, audiology, dentistry, and pain management. Failing to coordinate care can lead to suboptimal outcomes [1], [5].
• Over-Restriction of Activity: While caution is necessary, excessive restriction of physical activity can lead to muscle atrophy and further bone demineralization, exacerbating the disease [5]. Encourage safe weight-bearing exercise where appropriate.

FAQ

Frequently Asked Questions

1. Is Osteogenesis Imperfecta always inherited?

No. While most cases are inherited in an autosomal dominant fashion, approximately 25-30% of cases are due to new (de novo) gene mutations, meaning there is no family history [6], [9]. Recessive forms are also recognized but are less common [1], [4].

2. Can OI be cured?

Currently, there is no cure for Osteogenesis Imperfecta. Management focuses on preventing fractures, managing pain, optimizing bone health with medications like bisphosphonates, and addressing skeletal deformities through orthopedic interventions and rehabilitation [1], [5].

3. Are all fractures in a child with OI considered 'normal'?

No. While individuals with OI are prone to fractures, not every fracture should be automatically attributed to the disease. The mechanism and pattern of fractures should always be evaluated. Fracture patterns that are highly specific for abuse (e.g., posteromedial rib fractures, metaphyseal corner fractures) should still prompt consideration of non-accidental trauma, even in a child with diagnosed OI [18], [19].

4. What is the role of bisphosphonates in OI?

Bisphosphonates are a cornerstone of medical management for moderate to severe OI. They work by reducing bone resorption, which leads to increased bone mineral density and decreased fracture rates. They do not cure the underlying collagen defect but significantly improve bone strength and reduce pain [1], [11]. Intravenous pamidronate and zoledronic acid are commonly used [11].

5. Do all individuals with OI have blue sclerae?

No. While blue sclerae are a classic feature, especially in Type I OI, they are not universally present across all types. In some severe types (e.g., Type III), the sclerae may appear white or grey, and in Type IV, they can be normal [1].

References

1. [1] Subramanian S, Anastasopoulou C, Viswanathan VK. Osteogenesis Imperfecta. StatPearls [Internet], StatPearls Publishing; updated February 2023 (academic): https://www.ncbi.nlm.nih.gov/books/NBK536957/
2. [2] GeneReviews. COL1A1- and COL1A2-Related Osteogenesis Imperfecta. University of Washington, Seattle (academic): https://www.ncbi.nlm.nih.gov/books/NBK1295/
3. [3] National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Osteogenesis Imperfecta (government): https://www.niams.nih.gov/health-topics/osteogenesis-imperfecta
4. [4] Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016;387(10028):1657-1671 (academic): https://pmc.ncbi.nlm.nih.gov/articles/PMC7384887/
5. [5] NIAMS. Osteogenesis Imperfecta: Diagnosis, Treatment, and Steps to Take (government): https://www.niams.nih.gov/health-topics/osteogenesis-imperfecta/diagnosis-treatment-and-steps-to-take
6. [6] Osteogenesis Imperfecta Foundation. Child Abuse or Osteogenesis Imperfecta? (professional body): https://oif.org/child-abuse-or-osteogenesis-imperfecta/
7. [7] Orphanet. Osteogenesis imperfecta (ORPHA:666) (academic): https://www.orpha.net/en/disease/detail/666
8. [8] Osteogenesis Imperfecta Foundation. OI Types and Genetics (professional body): https://oif.org/oi-types-and-genetics/
9. [9] National Organization for Rare Disorders (NORD). Osteogenesis Imperfecta (professional body): https://rarediseases.org/rare-diseases/osteogenesis-imperfecta/
10. [10] Daley SF, Gonzalez D, Bethencourt Mirabal A, Afzal M. Child Abuse and Neglect. StatPearls [Internet], StatPearls Publishing (academic): https://www.ncbi.nlm.nih.gov/books/NBK459146/
11. [11] Dwan K, Phillipi CA, Steiner RD, et al. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database of Systematic Reviews. 2016;(10):CD005088 (academic): https://pmc.ncbi.nlm.nih.gov/articles/PMC6611487/
12. [12] OrthoInfo (AAOS). Osteogenesis Imperfecta (professional body): https://www.orthoinfo.org/diseases--conditions/osteogenesis-imperfecta/
13. [13] Dahash BA, Sankararaman S. Rickets. StatPearls [Internet], StatPearls Publishing (academic): https://www.ncbi.nlm.nih.gov/books/NBK562285/
14. [14] NIAMS. Juvenile Osteoporosis (government): https://www.niams.nih.gov/health-topics/juvenile-osteoporosis
15. [15] GeneReviews. Hypophosphatasia. University of Washington, Seattle (academic): https://www.ncbi.nlm.nih.gov/books/NBK1150/
16. [16] The Ehlers-Danlos Society. What is EDS? (professional body): https://www.ehlers-danlos.com/what-is-eds/
17. [17] GeneReviews. Loeys-Dietz Syndrome. University of Washington, Seattle (academic): https://www.ncbi.nlm.nih.gov/books/NBK1133/
18. [18] Dwek JR. The Radiographic Approach to Child Abuse. Clin Orthop Relat Res. 2011;469(3):776-789 (academic): https://pmc.ncbi.nlm.nih.gov/articles/PMC3032862/
19. [19] Knight DJ, Bennet GC. Nonaccidental injury in osteogenesis imperfecta: a case report. J Pediatr Orthop. 1990;10(4):542-544 (academic): https://pubmed.ncbi.nlm.nih.gov/2358497/